Digital Content 
NEWS #PharmaBuzz
13 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/13/2929048/0/en/Praxis-Precision-Medicines-Provides-Corporate-Update-and-Reports-Second-Quarter-2024-Financial-Results.html
12 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/12/2862133/0/en/Praxis-Precision-Medicines-to-Present-on-Ulixacaltamide-at-the-American-Academy-of-Neurology-2024-Annual-Meeting.html
05 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/01/05/2804615/0/en/Praxis-Precision-Medicines-Announces-Licensing-and-Collaboration-Agreement-with-Tenacia-Biotechnology-for-Ulixacaltamide-in-Greater-China.html
08 Aug 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/08/08/2720429/0/en/Praxis-Precision-Medicines-Announces-Positive-Data-from-Randomized-Withdrawal-Sub-Study-and-Long-Term-Extension-of-Essential1-Study-for-Ulixacaltamide.html
09 Jun 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/06/09/2685440/0/en/Praxis-Precision-Medicines-Announces-Plans-to-Begin-Ulixacaltamide-Phase-3-in-Essential-Tremor-by-Year-End-After-Completing-End-of-Phase-2-Meeting-with-FDA.html
17 Apr 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/04/17/2647849/0/en/Praxis-Precision-Medicines-Announces-Upcoming-Ulixacaltamide-Presentations-Events.html
Share 